3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
190
Leukemia, Lymphocytic, Chronic, B-Cell
69
Myelodysplastic Syndromes
48
Recurrence
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Mantle-Cell
21
Leukemia, Myelomonocytic, Chronic
20
Leukemia, Biphenotypic, Acute
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
14
Hematologic Neoplasms
14
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Burkitt Lymphoma
13
Lymphoma, B-Cell, Marginal Zone
12
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms
10
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Neoplasm, Residual
6
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
GATA2 Deficiency
4
Leukemia, Monocytic, Acute
3
Leukemia, B-Cell
3
Interventions
pembrolizumab
59
Cisplatin
45
Cetuximab
29
Radiotherapy
26
Carboplatin
24
Docetaxel
17
Paclitaxel
16
Nivolumab
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
Standard of Care
8
tislelizumab
7
cemiplimab
6
atezolizumab
6
Radiation
6
Chemoradiotherapy
6
toripalimab
5
Cyclophosphamide
5
130-nm albumin-bound paclitaxel
5
nimotuzumab
4
fludarabine
4
durvalumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Afatinib
4
palbociclib
3
niraparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
venetoclax
×
1 year
×
Clear all
No trials found.